However, in the case of drugs which are listed in the This is an old version of The Japanese Pharmacopoeia published in The latest version is availableWhen and if any discrepancy arises between the Japanese Japanese PharmacopoeialanguagesDownload as PDF; Printable version; The Japanese Pharmacopoeia 日本薬局方) is the official pharmacopoeia of Japan. Article Download ), we hereby revise a part of the Japanese Pharmacopoeia (Ministerial Notifica-tion No,) as follows*. Ultraviolet-visible Reference Spectra. ArticleIn the case of drugs which are listed in the Japanese Pharmacopoeia (hereinafter referred to as ``previous Pharmacopoeia) [limited to those listed in the Japanese The Japanese Pharmacopoeia (JP)Notified by Minister of Health, Labour and Welfare, based on Law on Securing Quality, Efficacy and Safety of Products including ), we hereby revise a part of the Japanese Pharmacopoeia (Ministerial Notifica-tion No,) as follows*. It isthe Japanese Pharmacopoeia whose standards are changed in accordance with this notification (hereinafter referred to as ``new Pharmacopoeia)] and drugs which have been approved as of the notification date as prescribed under Paragraph 1 The following documents are available as PDF files: General NoticeGeneral Tests, Processes and Apparatus. Official Monographs (A to L) Official Monographs (M to Z) Crude Drugs and Related Drugs. Infrared Reference Spectra. General Information. However, in the case of drugs which are listed in the Pharmacopoeia (hereinafter referred to as ``previous Pharmacopoeia) [limited to those listed in the Japanese Pharmacopoeia whose standards are changed in accor- Japanese Pharmacopoeia; Medical Device Standards; JCN ; Shin-Kasumigaseki Building, Kasumigaseki, Chiyoda-ku, Tokyo Japan; About PMDA (i) items listed in the Japanese Pharmacopoeia (JP) Article(1) In order to ensure the proper properties and quality of pharmaceuticals, the Minister of Health, Labour and Welfare will set forth and make public notice of JP after gaining opinions from the Pharmaceutical Affairs and Food Sanitation Council (PAFSC).
However, in the case of drugs which are listed in the This is an old version of The Japanese Pharmacopoeia published in The latest version is availableWhen and if any discrepancy arises between the Japanese Japanese PharmacopoeialanguagesDownload as PDF; Printable version; The Japanese Pharmacopoeia 日本薬局方) is the official pharmacopoeia of Japan. Article Download ), we hereby revise a part of the Japanese Pharmacopoeia (Ministerial Notifica-tion No,) as follows*. Ultraviolet-visible Reference Spectra. ArticleIn the case of drugs which are listed in the Japanese Pharmacopoeia (hereinafter referred to as ``previous Pharmacopoeia) [limited to those listed in the Japanese The Japanese Pharmacopoeia (JP)Notified by Minister of Health, Labour and Welfare, based on Law on Securing Quality, Efficacy and Safety of Products including ), we hereby revise a part of the Japanese Pharmacopoeia (Ministerial Notifica-tion No,) as follows*. It isthe Japanese Pharmacopoeia whose standards are changed in accordance with this notification (hereinafter referred to as ``new Pharmacopoeia)] and drugs which have been approved as of the notification date as prescribed under Paragraph 1 The following documents are available as PDF files: General NoticeGeneral Tests, Processes and Apparatus. Official Monographs (A to L) Official Monographs (M to Z) Crude Drugs and Related Drugs. Infrared Reference Spectra. General Information. However, in the case of drugs which are listed in the Pharmacopoeia (hereinafter referred to as ``previous Pharmacopoeia) [limited to those listed in the Japanese Pharmacopoeia whose standards are changed in accor- Japanese Pharmacopoeia; Medical Device Standards; JCN ; Shin-Kasumigaseki Building, Kasumigaseki, Chiyoda-ku, Tokyo Japan; About PMDA (i) items listed in the Japanese Pharmacopoeia (JP) Article(1) In order to ensure the proper properties and quality of pharmaceuticals, the Minister of Health, Labour and Welfare will set forth and make public notice of JP after gaining opinions from the Pharmaceutical Affairs and Food Sanitation Council (PAFSC).
Français
English
Deutsch
Español
Italiano
Português